JAZZ PHARMACEUTICALS INC 4
4 · JAZZ PHARMACEUTICALS INC · Filed Jun 6, 2007
Insider Transaction Report
Form 4
Wissel Janne LT
SVP, Chief Regulatory Officer
Transactions
- Conversion
Common Stock
2007-06-06+66,264→ 96,082 total - Conversion
Series B Preferred Stock
2007-06-06−66,264→ 0 total→ Common Stock (66,264 underlying)
Footnotes (2)
- [F1]The Issuer's Preferred Stock automatically converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and had no expiration date.
- [F2]Includes 2,485 shares subject to the Issuer's unvested share repurchase right as of May 30, 2007.